Switch From Ritonavir to Cobicistat in HIV With Dyslipidemia Switch From Ritonavir to Cobicistat in HIV With Dyslipidemia

A new study examines the impact of switching from ritonavir to cobicistat on lipid parameters among virologically suppressed HIV-infected patients with dyslipidemia.HIV Medicine

Source: Medscape Today Headlines - January 18, 2018 Category: Consumer Health News Tags: HIV/AIDS Journal Article Source Type: news